Anderson LJ, Boyles JK, Hussain MM (1989) A rapid method for staining large chylomicrons. J. Lipid Res. 30:1819–1824.
Boström K, Lauer SJ, Poksay KS, Garcia Z, Taylor JM, Innerarity TL (1989) Apolipoprotein B48 RNA editing in chimeric apolipoprotein EB mRNA. J. Biol. Chem. 264:15701–15708.
Boyles JK, Zoellner CD, Anderson LJ, Kosik LM, Pitas RE, Weisgraber KH, Hui DY, Mahley RW, Gebicke-Haerter PJ, Ignatius MJ, Shooter EM (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest. 83:1015–1031.
Brown DL, Phillips DR, Damsky CH, Charo IF (1989) Synthesis and expression of the fibroblast fibronectin receptor in human monocytes. J. Clin. Invest. 84:366–370.
Chappell DA (1989) High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia). J. Clin. Invest. 84:1906–1915.
Fitzgerald LA, Phillips DR (1989) Structure and function of platelet membrane glycoproteins. In: Platelet Immunobiology. Molecular and Clinical Aspects (Kunicki TJ, George JN, eds) JB Lippincott, Philadelphia, pp 9–30.
Fox JEB, Berndt MC (1989) Cyclic AMP-dependent phosphorylation of glycoprotein Ib inhibits collagen-induced polymerization of actin in platelets. J. Biol. Chem. 264:9520–9526.
Gong EL, Nichols AV, Weisgraber KH, Forte TM, Shore VG, Blanche PJ (1989) Discoidal complexes containing apolipoprotein E and their transformation by lecithin–cholesterol acyltransferase. Biochim. Biophys. Acta 1006:317–328.
Hussain MM, Mahley RW, Boyles JK, Fainaru M, Brecht WJ, Lindquist PA (1989) Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake. J. Biol. Chem. 264:9571–9582.
Hussain MM, Mahley RW, Boyles JK, Lindquist PA, Brecht WJ, Innerarity TL (1989) Chylomicron metabolism. Chylomicron uptake by bone marrow in different animal species. J. Biol. Chem. 264:17931–17938.
Lalazar A, Ou S-HI, Mahley RW (1989) Human apolipoprotein E. Receptor binding activity of truncated variants with carboxyl-terminal deletions. J. Biol. Chem. 264:8447–8450.
Levy-Wilson B, Fortier C (1989) Tissue-specific undermethylation of DNA sequences at the 5′ end of the human apolipoprotein B gene. J. Biol. Chem. 264:9891–9896.
Levy-Wilson B, Fortier C (1989) The limits of the DNase I-sensitive domain of the human apolipoprotein B gene coincide with the locations of chromosomal anchorage loops and define the 5′ and 3′ boundaries of the gene. J. Biol. Chem. 264:21196–21204.
Ludwig EH, Friedl W, McCarthy BJ (1989) High-resolution analysis of a hypervariable region in the human apolipoprotein B gene. Am. J. Hum. Genet. 45:458–464.
Mahley RW, Bersot TP (1989) Lipid abnormalities: Mechanisms, clinical classifications, and management. In: Cardiology (Parmley WW, Chatterjee K, eds) JB Lippincott, Philadelphia, pp 1–16.
Mahley RW, Boyles JK, Pitas RE (1989) Role of apolipoprotein E and high density lipoproteins in lipid redistribution locally within tissues. In: High Density Lipoproteins and Atherosclerosis II (Miller NE, ed) Elsevier Science, Amsterdam, pp 263–268.
Mahley RW, Hui DY, Innerarity TL, Beisiegel U (1989) Chylomicron remnant metabolism. Role of hepatic lipoprotein receptors in mediating uptake. Arteriosclerosis 9:I-14–I-18.
Mahley RW, Rall SC Jr (1989) Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: The Metabolic Basis of Inherited Disease, 6th edition (Scriver CR, Beaudet AL, Sly WS, Valle D, eds) McGraw-Hill, New York, pp 1195–1213.
Mahley RW, Weisgraber KH, Hussain MM, Greenman B, Fisher M, Vogel T, Gorecki M (1989) Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits. J. Clin. Invest. 83:2125–2130.
Maurice R, Marcel YL, Innerarity TL, Milne RW (1989) A potential complication in the use of monoclonal antibodies: Inhibition of apoB-mediated receptor binding by an anti-apoE antibody. J. Lipid Res. 30:587–596.
Rall SC Jr, Newhouse YM, Clarke HRG, Weisgraber KH, McCarthy BJ, Mahley RW, Bersot TP (1989) Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant. J. Clin. Invest. 83:1095–1101.
Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ (1989) Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc. Natl. Acad. Sci. USA 86:587–591.
Wardell MR, Reynolds CC, Berndt MC, Wallace RW, Fox JEB (1989) Platelet glycoprotein Ibβ is phosphorylated on serine 166 by cyclic AMP-dependent protein kinase. J. Biol. Chem. 264:15656–15661.
Wardell MR, Weisgraber KH, Havekes LM, Rall SC Jr (1989) Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121–127. J. Biol. Chem. 264:21205–21210.
Weisgraber KH, Newhouse YM, Taylor JM, Tuan B, Nestruck AC, Davignon J, Mahley RW (1989) Apolipoprotein E2(Arg158→Cys) frequency in a hyperlipidemic French-Canadian population of apolipoprotein E2/2 subjects. Determination by synthetic oligonucleotide probes. Arteriosclerosis 9:50–57.
Wernette-Hammond ME, Garcia Z, Arnold KS, Innerarity TL (1989) β-very low density lipoprotein uptake in cultured fibroblasts and smooth muscle cells from Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis 9:501–510.
Wernette-Hammond ME, Lauer SJ, Corsini A, Walker D, Taylor JM, Rall SC Jr (1989) Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. J. Biol. Chem. 264:9094–9101.
Young SG, Hubl ST (1989) An ApaLI restriction site polymorphism is associated with the MB19 polymorphism in apolipoprotein B. J. Lipid Res. 30:443–449.
Young SG, Hubl ST, Chappell DA, Smith RS, Claiborne F, Snyder SM, Terdiman JF (1989) Familial hypobetalipoproteinemia associated with a mutant species of apolipoprotein B (B46). N. Engl. J. Med. 320:1604–1610.
TOP
